In last trading session, CorMedix Inc (NASDAQ:CRMD) saw 1.18 million shares changing hands with its beta currently measuring 1.62. Company’s recent per share price level of $6.30 trading at $0.23 or 3.79% at ring of the bell on the day assigns it a market valuation of $410.64M. That closing price of CRMD’s stock is at a discount of -119.84% from its 52-week high price of $13.85 and is indicating a premium of 42.7% from its 52-week low price of $3.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.49 million shares which gives us an average trading volume of 1.44 million if we extend that period to 3-months.
For CorMedix Inc (CRMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.19 in the current quarter.
CorMedix Inc (NASDAQ:CRMD) trade information
Upright in the green during last session for gaining 3.79%, in the last five days CRMD remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $6.30 price level, adding 11.39% to its value on the day. CorMedix Inc’s shares saw a change of -22.22% in year-to-date performance and have moved -12.01% in past 5-day. CorMedix Inc (NASDAQ:CRMD) showed a performance of -36.04% in past 30-days. Number of shares sold short was 8.18 million shares which calculate 10.23 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 9 to the stock, which implies a rise of 30.0% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -42.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of -42.86% for stock’s current value.
CorMedix Inc (CRMD) estimates and forecasts
This year revenue growth is estimated to rise 187.19% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 32.2M for the same. And 5 analysts are in estimates of company making revenue of 25.91M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.80% during past 5 years.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
Insiders are in possession of 1.17% of company’s total shares while institution are holding 37.80 percent of that, with stock having share float percentage of 38.24%. Investors also watch the number of corporate investors in a company very closely, which is 37.80% institutions for CorMedix Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at CRMD for having 3.55 million shares of worth $15.39 million. And as of 2024-06-30, it was holding 6.167 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 2.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.0476 of outstanding shares, having a total worth of $12.57 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.73 shares of worth $10.91 million or 2.66% of the total outstanding shares. The later fund manager was in possession of 1.57 shares on Feb 28, 2025 , making its stake of worth around $9.89 million in the company or a holder of 2.41% of company’s stock.
